Sensitive quantification of sirolimus and everolimus by LC-MS/MS with online sample cleanup

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 878, Issue 13-14, 2010, Pages 1007-1012

  Mueller, Daniel M ^a   Rentsch, Katharina M ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Everolimus; LC MS MS; Online sample cleanup; Sirolimus

Indexed keywords

ANALYTES; AUTOSAMPLERS; CHEMICAL IONIZATION; EVEROLIMUS; HIGH-THROUGHPUT; IMMUNOSUPPRESSIVE AGENT; INTERNAL STANDARDS; IONIZATION MODES; LC-MS/MS; LOWER LIMIT OF QUANTIFICATIONS; MATRIX EFFECTS; ONLINE EXTRACTION; REVERSED PHASE CHROMATOGRAPHY; SAMPLE CLEAN-UP; SIROLIMUS; THERAPEUTIC DRUG MONITORING; TRANSPLANTATION MEDICINE; WHOLE BLOOD;

CHEMICAL DETECTION; IONIZATION; MASS SPECTROMETRY; PARTICLE DETECTORS; PATIENT MONITORING; TURBULENT FLOW;

CHROMATOGRAPHY;

EVEROLIMUS; RAPAMYCIN;

ARTICLE; HIGH THROUGHPUT SCREENING; IONIZATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PRIORITY JOURNAL; REVERSED PHASE LIQUID CHROMATOGRAPHY; TURBULENT FLOW CHROMATOGRAPHY;

CHROMATOGRAPHY, LIQUID; HUMANS; IMMUNOSUPPRESSIVE AGENTS; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SIROLIMUS; TANDEM MASS SPECTROMETRY;

EID: 77950298821     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2010.02.029     Document Type: Article

References (27)

1. Sehgal S.N., Baker H., and Vezina C. J. Antibiot. (Tokyo) 28 (1975) 727
2. Monchaud C., and Marquet P. Clin. Pharmacokinet. 48 (2009) 489
3. Faivre S., Kroemer G., and Raymond E. Nat. Rev. Drug Discov. 5 (2006) 671
4. Shillingford J., Murcia N., Larson C., Low S., Hedgepeth R., Brown N., Flask C., Novick A., Goldfarb D., and Kramer-Zucker A. Proc. Natl. Acad. Sci. 103 (2006) 5466
5. Mahalati K., and Kahan B. Clin. Pharmacokinet. 40 (2001) 573
6. Korecka M., and Shaw L.M. Ann. Transplant. 14 (2009) 61
7. Salm P., Taylor P.J., and Pillans P.I. Clin. Ther. 22 Suppl. B (2000) B71
8. Khoschsorur G. Clin. Chem. 51 (2005) 1721
9. Bogusz M.J., Enazi E.A., Hassan H., Abdel-Jawaad J., Ruwaily J.A., and Tufail M.A. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 850 (2007) 471
10. Taylor P.J., Franklin M.E., Graham K.S., and Pillans P.I. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 848 (2007) 208
11. Vogeser M., Fleischer C., Meiser B., Groetzner J., Spohrer U., and Seidel D. Clin. Chem. Lab. Med. 40 (2002) 40
12. Ceglarek U., Lembcke J., Fiedler G.M., Werner M., Witzigmann H., Hauss J.P., and Thiery J. Clin. Chim. Acta 346 (2004) 181
13. Christians U., Jacobsen W., Serkova N., Benet L.Z., Vidal C., Sewing K.F., Manns M.P., and Kirchner G.I. J. Chromatogr. B: Biomed. Sci. Appl. 748 (2000) 41
14. Deters M., Kirchner G., Resch K., and Kaever V. Clin. Chem. Lab. Med. 40 (2002) 285
15. Kirchner G.I., Vidal C., Jacobsen W., Franzke A., Hallensleben K., Christians U., and Sewing K.F. J. Chromatogr. B: Biomed. Sci. Appl. 721 (1999) 285
16. Korecka M., Solari S.G., and Shaw L.M. Ther. Drug Monit. 28 (2006) 484
17. Koster R.A., Dijkers E.C., and Uges D.R. Ther. Drug Monit. 31 (2009) 116
18. Seger C., Tentschert K., Stoggl W., Griesmacher A., and Ramsay S.L. Nat. Protoc. 4 (2009) 526
19. Volosov A., Napoli K.L., and Soldin S.J. Clin. Biochem. 34 (2001) 285
20. Wallemacq P.E., Vanbinst R., Asta S., and Cooper D.P. Clin. Chem. Lab. Med. 41 (2003) 921
21. Wang S., and Miller A. Clin. Chem. Lab. Med. 46 (2008) 1631
22. Ansermot N., Fathi M., Veuthey J.L., Desmeules J., Rudaz S., and Hochstrasser D. Clin. Biochem. 41 (2008) 728
23. Streit F., Armstrong V.W., and Oellerich M. Clin. Chem. 48 (2002) 955
24. Bonfiglio R., King R.C., Olah T.V., and Merkle K. Rapid Commun. Mass Spectrom. 13 (1999) 1175
25. Gutteck-Amsler U., and Rentsch K.M. Ther. Drug Monit. 23 (2001) 470
26. FDA, http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM070107.pdf (accessed 2009).
27. McMahon L.M., Luo S., Hayes M., and Tse F.L. Rapid Commun. Mass Spectrom. 14 (2000) 1965